ATXN1 and neurodegenerative disease: The polyQ-ataxin-1 phase transition model that we propose (Fig. 10) will thus provide a framework for ongoing investigations to contribute new knowledge to a mechanistic understanding how polyQ-ataxin-1 can drive the pathological changes observed in the neurodegenerative disease SCA1.